Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1999
12/29/1999WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor
12/29/1999WO1999055830A3 Process for synthesizing cox-2 inhibitors
12/29/1999WO1999055339A8 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
12/29/1999WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
12/29/1999WO1999051626A3 Template associated npy y2-receptor agonists
12/29/1999WO1999044597A3 Use of macrolide compounds for the treatment of ards
12/29/1999EP0967284A1 Phosphodiesterases
12/29/1999EP0967207A1 Nitrone derivatives, process for their preparation and pharmaceutical compositions containing them
12/29/1999EP0966969A1 Anti-stress drugs and functional foods having anti-stress effects
12/29/1999EP0966968A1 Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2
12/29/1999EP0966965A1 Methods for reducing levels of homocysteine and C-reactive protein
12/29/1999EP0966964A1 Methods for increasing levels of acetylcholine
12/29/1999EP0966536A1 Factor x analogues with a modified protease cleavage site
12/29/1999EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii)
12/29/1999EP0966530A2 Secreted proteins and polynucleotides encoding them
12/29/1999EP0966525A1 Method of using tetracycline compounds for inhibition of nitric oxide production
12/29/1999EP0966487A1 Polyvalent carbohydrate molecules
12/29/1999EP0966484A1 Neurotactin and uses therefor
12/29/1999EP0966476A1 Quinazolinone compounds
12/29/1999EP0966473A1 Thiazolobenzoheterocycles, preparation and medicines containing same
12/29/1999EP0966470A1 Dioxino derivatives and their use as therapeutic agents
12/29/1999EP0966465A1 Inhibitors of impdh enzyme
12/29/1999EP0966463A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
12/29/1999EP0966455A1 Oxiran carboxylic acids for the treatment of diabetes
12/29/1999EP0966447A1 Small molecules useful in the treatment of inflammatory disease
12/29/1999EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
12/29/1999EP0966442A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
12/29/1999EP0966438A1 N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
12/29/1999EP0966437A1 5-aroylnaphthalene derivatives
12/29/1999EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes
12/29/1999EP0966302A1 Methods of therapeutic administration of anti-cd40l compounds
12/29/1999EP0966299A2 Novel pharmaceutical compositions
12/29/1999EP0966295A1 Calcareous material
12/29/1999EP0966294A1 Bifurcated method to process aloe whole leaf
12/29/1999EP0966293A1 Medicine for promoting cicatrization and containing thrombocytes
12/29/1999EP0966292A1 Mononuclear phagocytes and their use to promote axonal regeneration
12/29/1999EP0966286A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain
12/29/1999EP0966283A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
12/29/1999EP0966277A1 Use of r-nsaid's for the prevention of alzheimer's disease
12/29/1999EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
12/29/1999EP0785932B1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists
12/29/1999EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy
12/29/1999EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof
12/29/1999EP0379483B1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES
12/29/1999CN1239964A Tetraphosphonate bicyclic trisanhydrides
12/29/1999CN1239962A 1,4-diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
12/29/1999CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels
12/29/1999CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors
12/29/1999CN1239950A New derivates from piperidine-keto acid, their preparation and use
12/29/1999CN1239949A Novel heterocyclically substituted benzamides and their use in fighting diseases
12/29/1999CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs.
12/29/1999CN1239894A Inositol polyphosphate derivatives and method of using same
12/29/1999CN1239893A Hormonal composition consisting of oestrogen compound and progestational compound
12/29/1999CN1239888A Method for inhibiting stress-activated protein kinases
12/29/1999CN1239886A Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent
12/29/1999CN1239718A 11-acetyl-12,13-dioxa bicyclo [8.2.1] tridecenone -derivative, its preparation and medicine containing the compound
12/29/1999CN1047775C N-piperidino 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl pyrazole-3-formyl amide, its preparation and drug composition
12/29/1999CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
12/29/1999CA2336201A1 Compositions and methods for inhibiting bone resorption
12/29/1999CA2336192A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999CA2336160A1 Use of compounds for treating hiv
12/29/1999CA2336135A1 Mumbaistatin, a process for its production and its use as a pharmaceutical
12/29/1999CA2336003A1 Amidino and guanidino azetidinone tryptase inhibitors
12/29/1999CA2335992A1 Prodrugs of dipeptidyl peptidase iv inhibitors
12/29/1999CA2335989A1 Stable no-delivering compounds
12/29/1999CA2335978A1 Compounds of unstable dipeptidyl peptidase iv inhibitors
12/29/1999CA2335939A1 Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient
12/29/1999CA2335876A1 Protease inhibitors
12/29/1999CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999CA2335809A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999CA2335711A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use
12/29/1999CA2335545A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
12/29/1999CA2335513A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999CA2335329A1 Meiosis regulating compounds
12/29/1999CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones
12/29/1999CA2335190A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases
12/29/1999CA2334645A1 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999CA2333750A1 Adjuvant therapy
12/29/1999CA2333586A1 Matrix-type transdermal patch for steroid hormones
12/29/1999CA2330542A1 Human arf-related proteins
12/29/1999CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999CA2330175A1 Ependymal neural stem cells and method for their isolation
12/29/1999CA2330026A1 Compositions and methods for delivery of agents for altering neuronal growth, regeneration, and survival
12/29/1999CA2329939A1 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof
12/29/1999CA2329755A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/29/1999CA2325389A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999CA2325388A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/28/1999US6008417 Oxidative dehydroxylation, oxidative cleaving, intramolecular aldol condensation, silylation, c3-chain lengthening and simultaneous saponification, reaction with vinylmagnesium bromide, deprotection, and wittig reaction
12/28/1999US6008351 Peptide aldehyde compounds having uracil or pyrimidin-4-one groups as part of the peptide backbone; potent inhibitors of thrombin
12/28/1999US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents
12/28/1999US6008336 Compacted nucleic acids and their delivery to cells
12/28/1999US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent
12/28/1999US6008245 Treatment of prophylaxis and cardiovascular disorders, in particular arrhythmias, for the treatment of ulcers of the gastrointestinal disorders, diarrheal diseases
12/28/1999US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues
12/28/1999US6008233 (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
12/28/1999US6008231 Antiallergens, antihistamines, immunosuppressants, immunomodulators
12/28/1999US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain